Introduction: In addition, several recent studies have focused on the neutralizing activity of vaccine-elicited humoral immunity against new circulating mutant lineages, including B.1.1.7 (United Kingdom, bearing mutations 69-70 del, 144 del,
N501Y,
A570D,
D614G,
P681H,
T716I,
S982A, and
D1118H in the
spike protein), B.1.429 (United States, bearing mutations
S13I,
W152C,
L452R, and
D614G in the
spike protein), B.1.351(South Africa, bearing mutations
D80A,
D215G,
PMID: 34534263
2021
PLoS pathogens
Method: We used the following amino acids replacements and deletions in
Spike for each lineage-based COG-UK defined changes for each lineage; Beta (B1.351;
L18F,
D80A,
D215G,
R246L,
K417N,
E484K,
N501Y,
A701V), Gamma (P.1;
L18F,
T20N,
P26S,
D138Y,
R190S,
K417T,
E484K,
N501Y H655Y,
T1027I), Alpha (B.1.1.7; Delta69-70, D144,